Massie A, Boillee S, Hewett S, Knackstedt L, Lewerenz J. Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission. J Neurochem. 2015;135:1062–79.
Massie A, Schallier A, Kim SW, Fernando R, Kobayashi S, Beck H, et al. Dopaminergic neurons of system x(c)(-)-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. FASEB J. 2011;25:1359–69.
De Bundel D, Schallier A, Loyens E, Fernando R, Miyashita H, Van Liefferinge J, et al. Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J Neurosci. 2011;31:5792–803.
Bridges R, Lutgen V, Lobner D, Baker DA. Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharm Rev. 2012;64:780–802.
Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci. 2005;25:6389–93.
Williams LE, Featherstone DE. Regulation of hippocampal synaptic strength by glial xCT. J Neurosci. 2014;34:16093–102.
Alcoreza O, Tewari BP, Bouslog A, Savoia A, Sontheimer H, Campbell SL. Sulfasalazine decreases mouse cortical hyperexcitability. Epilepsia. 2019;60:1365–77.
Bentea E, Demuyser T, Van Liefferinge J, Albertini G, Deneyer L, Nys J, et al. Absence of system xc- in mice decreases anxiety and depressive-like behavior without affecting sensorimotor function or spatial vision. Prog Neuropsychopharmacol Biol Psychiatry. 2015;59:49–58.
Shepherd GM. Corticostriatal connectivity and its role in disease. Nat Rev Neurosci. 2013;14:278–91.
Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011;472:437–42.
Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007;448:894–900.
Shmelkov SV, Hormigo A, Jing D, Proenca CC, Bath KG, Milde T, et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med. 2010;16:598–602. 1p following
Xu J, Marshall JJ, Fernandes HB, Nomura T, Copits BA, Procissi D, et al. Complete disruption of the kainate receptor gene family results in corticostriatal dysfunction in mice. Cell Rep. 2017;18:1848–57.
Nagarajan N, Jones BW, West PJ, Marc RE, Capecchi MR. Corticostriatal circuit defects in Hoxb8 mutant mice. Mol Psychiatry. 2018;23:1868–77.
Egawa J, Watanabe Y, Wang C, Inoue E, Sugimoto A, Sugiyama T, et al. Novel rare missense variations and risk of autism spectrum disorder: whole-exome sequencing in two families with affected siblings and a two-stage follow-up study in a Japanese population. PLoS One. 2015;10:e0119413.
Schellenberg GD, Dawson G, Sung YJ, Estes A, Munson J, Rosenthal E. et al. Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry. 2006;11:1049–60. 979.
Chen YW, Lin HC, Ng MC, Hsiao YH, Wang CC, Gean PW, et al. Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism. Front Behav Neurosci. 2014;8:219.
Egashira N, Shirakawa A, Abe M, Niki T, Mishima K, Iwasaki K, et al. N-acetyl-L-cysteine inhibits marble-burying behavior in mice. J Pharm Sci. 2012;119:97–101.
Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003;2:255–67.
Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, et al. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem. 2005;280:37423–9.
Conrad M, Sato H. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids. 2012;42:231–46.
McCullagh EA, Featherstone DE. Behavioral characterization of system xc- mutant mice. Behav Brain Res. 2014;265:1–11.
Ottestad-Hansen S, Hu QX, Follin-Arbelet VV, Bentea E, Sato H, Massie A, et al. The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain. Glia. 2018;66:951–70.
Bentea E, Sconce MD, Churchill MJ, Van Liefferinge J, Sato H, Meshul CK, et al. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT. Neurosci Lett. 2015;593:1–6.
Massie A, Schallier A, Mertens B, Vermoesen K, Bannai S, Sato H, et al. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. Neuroreport. 2008;19:1589–92.
Villers A, Ris L. Improved preparation and preservation of hippocampal mouse slices for a very stable and reproducible recording of long-term potentiation. J Vis Exp. 2013;76:e50483.
Hernandez A, Tan C, Mettlach G, Pozo K, Plattner F, Bibb JA. Cdk5 modulates long-term synaptic plasticity and motor learning in dorsolateral striatum. Sci Rep. 2016;6:29812.
Aerts J, Nys J, Moons L, Hu TT, Arckens L. Altered neuronal architecture and plasticity in the visual cortex of adult MMP-3-deficient mice. Brain Struct Funct. 2015;220:2675–89.
Toy WA, Petzinger GM, Leyshon BJ, Akopian GK, Walsh JP, Hoffman MV, et al. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease. Neurobiol Dis. 2014;63:201–9.
Bentea E, Moore C, Deneyer L, Verbruggen L, Churchill MJ, Hood RL, et al. Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson’s disease. Brain Res Bull. 2017;130:257–67.
Walker RH, Moore C, Davies G, Dirling LB, Koch RJ, Meshul CK. Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat. PLoS One. 2012;7:e32919.
Parievsky A, Moore C, Kamdjou T, Cepeda C, Meshul CK, Levine MS. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington’s disease. Neurobiol Dis. 2017;108:29–44.
Raju D, Smith Y. Differential localization of vesicular glutamate transporters 1 and 2 in the rat striatum. Advances in Behavioral Biology. Boston, MA: Springer; 2005. p. 601–10.
McGeorge AJ, Faull RL. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 1989;29:503–37.
Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience. 1999;88:1–16.
Meshul CK, Stallbaumer RK, Taylor B, Janowsky A. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res. 1994;648:181–95.
Dosemeci A, Tao-Cheng JH, Vinade L, Winters CA, Pozzo-Miller L, Reese TS. Glutamate-induced transient modification of the postsynaptic density. Proc Natl Acad Sci USA. 2001;98:10428–32.
Martone ME, Jones YZ, Young SJ, Ellisman MH, Zivin JA, Hu BR. Modification of postsynaptic densities after transient cerebral ischemia: a quantitative and three-dimensional ultrastructural study. J Neurosci. 1999;19:1988–97.
Upreti C, Otero R, Partida C, Skinner F, Thakker R, Pacheco LF, et al. Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy. Brain. 2012;135:869–85.
Lei W, Jiao Y, Del Mar N, Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J Neurosci. 2004;24:8289–99.
Uppal N, Puri R, Yuk F, Janssen WG, Bozdagi-Gunal O, Harony-Nicolas H, et al. Ultrastructural analyses in the hippocampus CA1 field in Shank3-deficient mice. Mol Autism. 2015;6:41.
Sullivan CR, Mielnik CA, O’Donovan SM, Funk AJ, Bentea E, DePasquale EA, et al. Connectivity analyses of bioenergetic changes in schizophrenia: identification of novel treatments. Mol Neurobiol. 2019;56:4492–517.
Bentea E, Depasquale EAK, O’Donovan SM, Sullivan CR, Simmons M, Meador-Woodruff JH, et al. Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia. Mol Omics. 2019;15:173–88.
McGuire JL, Depasquale EA, Funk AJ, O’Donnovan SM, Hasselfeld K, Marwaha S, et al. Abnormalities of signal transduction networks in chronic schizophrenia. NPJ Schizophr. 2017;3:30.
Ohori M, Kinoshita T, Okubo M, Sato K, Yamazaki A, Arakawa H, et al. Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. Biochem Biophys Res Commun. 2005;336:357–63.
Kalueff AV, Aldridge JW, LaPorte JL, Murphy DL, Tuohimaa P. Analyzing grooming microstructure in neurobehavioral experiments. Nat Protoc. 2007;2:2538–44.
Deacon RM. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc. 2006;1:122–4.
Rodriguez A, Zhang H, Klaminder J, Brodin T, Andersson PL, Andersson M. ToxTrac: a fast and robust software for tracking organisms. Methods Ecol Evol. 2018;9:460–4.
Chang YC, Cole TB, Costa LG. Behavioral phenotyping for autism spectrum disorders in mice. Curr Protoc Toxicol. 2017;72:11 22 1–11 22 1.
Yang M, Silverman JL, Crawley JN. Automated three-chambered social approach task for mice. Curr Protoc Neurosci. 2011;56:8.26.1–16.
Jensen CJ, Demol F, Bauwens R, Kooijman R, Massie A, Villers A, et al. Astrocytic beta2 adrenergic receptor gene deletion affects memory in aged mice. PLoS One. 2016;11:e0164721.
Frick RW. A better stopping rule for conventional statistical tests. Behav Res Methods, Instrum, Comput. 1998;30:690–7.
Appuhamy JA, Nayananjalie WA, England EM, Gerrard DE, Akers RM, Hanigan MD. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells. J Dairy Sci. 2014;97:419–29.
Gonzalez FA, Raden DL, Davis RJ. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem. 1991;266:22159–63.
LaCrosse AL, O’Donovan SM, Sepulveda-Orengo MT, McCullumsmith RE, Reissner KJ, Schwendt M, et al. Contrasting the role of xCT and GLT-1 upregulation in the ability of ceftriaxone to attenuate the cue-induced reinstatement of cocaine seeking and normalize AMPA receptor subunit expression. J Neurosci. 2017;37:5809–21.
Li Y, Tan Z, Li Z, Sun Z, Duan S, Li W. Impaired long-term potentiation and long-term memory deficits in xCT-deficient sut mice. Biosci Rep. 2012;32:315–21.
Zhou Y, Hassel B, Eid T, Danbolt NC. Axon-terminals expressing EAAT2 (GLT-1; Slc1a2) are common in the forebrain and not limited to the hippocampus. Neurochem Int. 2019;123:101–13.
Danbolt NC, Furness DN, Zhou Y. Neuronal vs glial glutamate uptake: resolving the conundrum. Neurochem Int. 2016;98:29–45.
Dahlmanns M, Yakubov E, Chen D, Sehm T, Rauh M, Savaskan N, et al. Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Disco. 2017;3:17030.
Kushner SA, Elgersma Y, Murphy GG, Jaarsma D, van Woerden GM, Hojjati MR, et al. Modulation of presynaptic plasticity and learning by the H-ras/extracellular signal-regulated kinase/synapsin I signaling pathway. J Neurosci. 2005;25:9721–34.
Thomas GM, Huganir RL. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci. 2004;5:173–83.
Sgambato V, Pages C, Rogard M, Besson MJ, Caboche J. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J Neurosci. 1998;18:8814–25.
Michetti C, Caruso A, Pagani M, Sabbioni M, Medrihan L, David G, et al. The knockout of synapsin ii in mice impairs social behavior and functional connectivity generating an ASD-like phenotype. Cereb Cortex. 2017;27:5014–23.
Harper KM, Hiramoto T, Tanigaki K, Kang G, Suzuki G, Trimble W, et al. Alterations of social interaction through genetic and environmental manipulation of the 22q11.2 gene Sept5 in the mouse brain. Hum Mol Genet. 2012;21:3489–99.
Huang MW, Lin YJ, Chang CW, Lei FJ, Ho EP, Liu RS, et al. RGS4 deficit in prefrontal cortex contributes to the behaviors related to schizophrenia via system xc(-)-mediated glutamatergic dysfunction in mice. Theranostics. 2018;8:4781–94.
Finlay JM, Dunham GA, Isherwood AM, Newton CJ, Nguyen TV, Reppar PC, et al. Effects of prefrontal cortex and hippocampal NMDA NR1-subunit deletion on complex cognitive and social behaviors. Brain Res. 2015;1600:70–83.
